Jeiwook Chae

Jeiwook Chae

Company: Legochem Biosciences

Job title: Chief Business Development Officer


Creating Next Generation ADCs with Industry-Leading DAR Precision, Plasma Stability, & Tumor-Selective Linker Payload Activation 1:00 pm

• LCB’s novel next-generation site-specific ADC platform technology • Proprietary cancer-selective linker providing significantly improved therapeutic index • Tumor-specific and ultra-potent DNA-damaging crosslinking payload with superior efficacy and reduced toxicityRead more

day: day 1 track 2 am

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.